3289617d53ee906221841a5fc1e47acff9f84c07
BCL2.md
| ... | ... | @@ -11,8 +11,8 @@ nocite: | |
| 11 | 11 | ## Overview |
| 12 | 12 | |
| 13 | 13 | BCL2 mutations are frequently found in DLBCL, particularly in the germinal center B-cell (GCB) subtype, and are often located in the flexible loop domain and outside the BCL2-homology domains. |
| 14 | -These mutations are caused by the somatic hypermutation process. The presence of these mutations are strongly correlated with the presence of a translocation between BCL2 and one of the immunoglobulin loci. |
|
| 15 | -Although missense mutations may not be under positive selective pressure in the context of lymphomagenesis, some of these mutations may interfere with the function of BCL2 antagonists. |
|
| 14 | +These mutations are caused by the somatic hypermutation process. The presence of these mutations are strongly correlated with the presence of a translocation between BCL2 and one of the immunoglobulin loci. |
|
| 15 | +[Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers. Although mutations may not be under positive selective pressure in the context of lymphomagenesis, some of these mutations may interfere with the function of BCL2 antagonists. |
|
| 16 | 16 | |
| 17 | 17 | |
| 18 | 18 | ## Relevance tier by entity |
BCL6.md
| ... | ... | @@ -10,7 +10,7 @@ nocite: | |
| 10 | 10 | ## Overview |
| 11 | 11 | |
| 12 | 12 | BCL6 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
| 13 | -Although common, particularly in DLBCL, the function of many of these mutations remains unclear but some have been shown to affect the regulation of BCL6 expression. The role of BCL6 missense mutations, seen over 9% of patients remains unclear. |
|
| 13 | +Although common, particularly in DLBCL, the function of many of these mutations remains unclear but some have been shown to affect the regulation of BCL6 expression. The role of BCL6 missense mutations remains unclear. |
|
| 14 | 14 | |
| 15 | 15 | |
| 16 | 16 | ## Experimental Evidence |
CIITA.md
| ... | ... | @@ -8,7 +8,7 @@ nocite: | |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| 10 | 10 | ## Overview |
| 11 | -CIITA encodes the major histocompatibility complex (MHC) class II transactivator. CIITA mutations are frequent in PMBCL. These mutations often include structural genomic rearrangements, missense, nonsense, and frameshift mutations. In PMBCL, these mutations are thought to contribute to loss of MHC expression.[@mottokGenomicAlterationsCIITA2015] Although loss of CIITA and MHC Class II Expression is commonly observed in DLBCL, the role of mutations and methylation affecting this locus remains unclear.[@morinFrequentMutationHistonemodifying2011] CIITA is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
|
| 11 | +CIITA encodes the major histocompatibility complex (MHC) class II transactivator. CIITA mutations are frequent in PMBCL. These mutations often include structural genomic rearrangements, missense, nonsense, and frameshift mutations. In PMBCL, these mutations are thought to contribute to loss of MHC expression.[@mottokGenomicAlterationsCIITA2015] Although loss of CIITA and MHC Class II Expression is commonly observed in DLBCL, the role of mutations and methylation affecting this locus remains unclear.[@morinFrequentMutationHistonemodifying2011] CIITA is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. The relevance of CIITA mutations in DLBCL remains unclear. [Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers. |
|
| 12 | 12 | |
| 13 | 13 | |
| 14 | 14 | ## Experimental Evidence |
ETS1.md
| ... | ... | @@ -32,6 +32,9 @@ The mutation pattern in DLBCL implies the preferential accumulation of *inactiva |
| 32 | 32 | ### FL |
| 33 | 33 | [[include:tables/FL_ETS1.md]] |
| 34 | 34 | |
| 35 | +### BL |
|
| 36 | +[[include:tables/BL_ETS1.md]] |
|
| 37 | + |
|
| 35 | 38 | ## Mutation pattern and selective pressure estimates |
| 36 | 39 | |
| 37 | 40 | [[include:tables/dnds_ETS1.md]] |
HIST1H2AM.md
| ... | ... | @@ -9,7 +9,7 @@ nocite: | |
| 9 | 9 | |
| 10 | 10 | ## Overview |
| 11 | 11 | |
| 12 | -This gene encodes the H2A protein, one of the core proteins comprising nucleosomes. Although relatively common in DLBCL, little is known about the function of these mutations. |
|
| 12 | +This gene encodes the H2A protein, one of the core proteins comprising nucleosomes. Although relatively common in DLBCL, little is known about the function of these mutations. The relevance of HIST1H2AM mutations in DLBCL remains unclear. [Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers. |
|
| 13 | 13 | |
| 14 | 14 | |
| 15 | 15 | ## Relevance tier by entity |
HIST1H2BC.md
| ... | ... | @@ -8,7 +8,8 @@ nocite: | |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| 10 | 10 | ## Overview |
| 11 | -This gene encodes the H2A protein, one of the core proteins comprising nucleosomes. Although relatively common in DLBCL, little is known about the function of these mutations. |
|
| 11 | +This gene encodes the H2A protein, one of the core proteins comprising nucleosomes. Although relatively common in DLBCL, little is known about the function of these mutations. The relevance of HIST1H2AC mutations in DLBCL remains unclear. |
|
| 12 | +[Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers. |
|
| 12 | 13 | |
| 13 | 14 | |
| 14 | 15 | ## Relevance tier by entity |
HIST1H3B.md
| ... | ... | @@ -7,6 +7,10 @@ nocite: | |
| 7 | 7 | --- |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| 10 | +## Overview |
|
| 11 | + |
|
| 12 | +The relevance of HIST1H3B mutations in DLBCL remains unclear. |
|
| 13 | +[Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers. |
|
| 10 | 14 | |
| 11 | 15 | ## Relevance tier by entity |
| 12 | 16 |
IGLL5.md
| ... | ... | @@ -7,6 +7,9 @@ nocite: | |
| 7 | 7 | --- |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| 10 | +## Overview |
|
| 11 | + |
|
| 12 | +Although IGLL5 is significantly mutated, [Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) implies the gene is largely under negative selective pressure. It remains unclear whether any of the mutations in IGLL5 are relevant to DLBCL, BL or FL. |
|
| 10 | 13 | |
| 11 | 14 | ## Relevance tier by entity |
| 12 | 15 |
IRF4.md
| ... | ... | @@ -10,8 +10,8 @@ nocite: | |
| 10 | 10 | ## Overview |
| 11 | 11 | IRF4 (Interferon Regulatory Factor 4) encodes a transcription factor that plays a critical role in the regulation of immune response genes and B-cell development. Mutations and rearrangements in the IRF4 gene have been implicated in various B-cell lymphomas, including DLBCL. |
| 12 | 12 | IRF4-rearranged large B-cell lymphomas (LBCL-IRF4) show a unique molecular profile with strong expression of IRF4/MUM1 and are associated with favorable outcomes. MUM1 staining is also commonly used to assign DLBCLs to one of the two cell-of-origin (COO) subgroups by immunohistochemistry. |
| 13 | -IRF4 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
|
| 14 | -There are a few mutation hotspots in this gene. The functional role of mutations in IRF4 in the absence of a rearrangement remains poorly understood. |
|
| 13 | +IRF4 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. Although IRF4 is significantly mutated in DLBCL, [Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) implies the gene is largely under negative selective pressure. |
|
| 14 | +There are a few mutation hotspots in IRF4. It remains unclear whether any of the mutations in IRF4 are relevant to lymphomagenesis. |
|
| 15 | 15 | |
| 16 | 16 | |
| 17 | 17 | ## Relevance tier by entity |
IRF8.md
| ... | ... | @@ -3,7 +3,7 @@ bibliography: 'morinlab.bib' |
| 3 | 3 | csl: 'NLM.csl' |
| 4 | 4 | link-citations: true |
| 5 | 5 | nocite: | |
| 6 | - @morinFrequentMutationHistonemodifying2011, @mottokIntegrativeGenomicAnalysis2019, @qiuIRF8mutantCellLymphoma2024, @wrightProbabilisticClassificationTool2020, @paneaWholeGenomeLandscape2019, |
|
| 6 | + @morinFrequentMutationHistonemodifying2011, @mottokIntegrativeGenomicAnalysis2019, @qiuIRF8mutantCellLymphoma2024, @wrightProbabilisticClassificationTool2020, @paneaWholeGenomeLandscape2019, @qiuIRF8mutantCellLymphoma2024 |
|
| 7 | 7 | --- |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| ... | ... | @@ -11,7 +11,7 @@ nocite: | |
| 11 | 11 | IRF8 (Interferon Regulatory Factor 8) is a transcription factor critical for the development and function of B lymphocytes. Mutations in IRF8 have been implicated in various lymphoid malignancies, most predominantly in FL and DLBCL. |
| 12 | 12 | IRF8 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
| 13 | 13 | Coding and non-coding mutations in IRF8 are associated with the EZB subgroup of DLBCL. |
| 14 | -There is preliminary evidence that IRF8 mutations contribute to immune evasion by downregulating CD74 and HLA-DM in DLBCL. |
|
| 14 | +There is preliminary evidence that IRF8 mutations contribute to immune evasion by downregulating CD74 and HLA-DM in DLBCL.[@qiuIRF8mutantCellLymphoma2024] |
|
| 15 | 15 | These are crucial for processing and presentation of self antigens. |
| 16 | 16 | |
| 17 | 17 |